Filing metadata

Accession number
0001209191-21-065762
Form type
Form 4
Filer
Trillium Therapeutics Inc.
CIK
CIK 1616212
Filed
Nov 19, 2021
Reporting period
Nov 17, 2021
Description
Insider transaction

Explore SEC Filings Hub

4 | SEC Filings Hub